Eligibility Leukemia NCT00602693

  1. StudyEvent: Eligibility
    1. Eligibility Leukemia NCT00602693
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
ages 18 to 75 years old
Description

ID.1

Data type

boolean

Alias
UMLS CUI [1]
C0001779
eligible for and co-enrolled on protocol umn-2005ls036, for treatment of any of the following advanced hematologic malignancies:
Description

ID.2

Data type

boolean

Alias
UMLS CUI [1]
C2347180
acute leukemias in complete remission (high risk cr1 or subsequent cr); chronic myelogenous leukemia (except refractory blast crisis); myelodysplastic syndrome with severe pancytopenia or complex cytogenetics, large-cell lymphoma, hodgkin's lymphoma and multiple myeloma, chronic lymphocytic leukemia/small lymphocytic lymphoma, marginal zone b-cell lymphoma, follicular lymphoma, lymphoplasmacytic lymphoma, mantle-cell lymphoma, prolymphocytic leukemia may be eligible after initial therapy.
Description

ID.3

Data type

boolean

Alias
UMLS CUI [1,1]
C0023418
UMLS CUI [1,2]
C3463824
UMLS CUI [1,3]
C0026764
UMLS CUI [1,4]
C0024299
have three partially hla matched umbilical cord blood (ucb) units (1-2 units for ucb transplantation per mt2005-02 and 1 unit for the treg cell infusion.)
Description

ID.4

Data type

boolean

Alias
UMLS CUI [1,1]
C0019721
UMLS CUI [1,2]
C0162371
adequate organ function
Description

ID.5

Data type

boolean

Alias
UMLS CUI [1]
C0678852
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
patients not exposed to highly immunosuppressive single agent or multi-agent chemotherapy within 3 months, or an ablative preparative regimen for autologous hematopoietic stem cell transplant (hct) within 1 year.
Description

ID.6

Data type

boolean

Alias
UMLS CUI [1,1]
C0021081
UMLS CUI [1,2]
C0392920
UMLS CUI [1,3]
C0472699
pregnancy or breastfeeding
Description

ID.7

Data type

boolean

Alias
UMLS CUI [1,1]
C0032961
UMLS CUI [1,2]
C0006147
current active serious infection
Description

ID.8

Data type

boolean

Alias
UMLS CUI [1]
C3714514
evidence of human immunodeficiency virus (hiv) or known hiv positive serology
Description

ID.9

Data type

boolean

Alias
UMLS CUI [1]
C0019682
patients with acute leukemia in morphologic relapse/persistent disease defined as >5% blasts in a > or = 15% cellular bone marrow or any % blasts if blasts have unique morphologic markers (e.g., auer rods) or associated cytogenetic markers that allows morphologic relapse to be distinguished are not eligible.
Description

ID.10

Data type

boolean

Alias
UMLS CUI [1]
C2367453
chronic myelogenous leukemia in refractory blast crisis.
Description

ID.11

Data type

boolean

Alias
UMLS CUI [1,1]
C1370868
UMLS CUI [1,2]
C0919644
active central nervous system malignancy.
Description

ID.12

Data type

boolean

Alias
UMLS CUI [1]
C0085136

Similar models

Eligibility Leukemia NCT00602693

  1. StudyEvent: Eligibility
    1. Eligibility Leukemia NCT00602693
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
ages 18 to 75 years old
boolean
C0001779 (UMLS CUI [1])
ID.2
Item
eligible for and co-enrolled on protocol umn-2005ls036, for treatment of any of the following advanced hematologic malignancies:
boolean
C2347180 (UMLS CUI [1])
ID.3
Item
acute leukemias in complete remission (high risk cr1 or subsequent cr); chronic myelogenous leukemia (except refractory blast crisis); myelodysplastic syndrome with severe pancytopenia or complex cytogenetics, large-cell lymphoma, hodgkin's lymphoma and multiple myeloma, chronic lymphocytic leukemia/small lymphocytic lymphoma, marginal zone b-cell lymphoma, follicular lymphoma, lymphoplasmacytic lymphoma, mantle-cell lymphoma, prolymphocytic leukemia may be eligible after initial therapy.
boolean
C0023418 (UMLS CUI [1,1])
C3463824 (UMLS CUI [1,2])
C0026764 (UMLS CUI [1,3])
C0024299 (UMLS CUI [1,4])
ID.4
Item
have three partially hla matched umbilical cord blood (ucb) units (1-2 units for ucb transplantation per mt2005-02 and 1 unit for the treg cell infusion.)
boolean
C0019721 (UMLS CUI [1,1])
C0162371 (UMLS CUI [1,2])
ID.5
Item
adequate organ function
boolean
C0678852 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
ID.6
Item
patients not exposed to highly immunosuppressive single agent or multi-agent chemotherapy within 3 months, or an ablative preparative regimen for autologous hematopoietic stem cell transplant (hct) within 1 year.
boolean
C0021081 (UMLS CUI [1,1])
C0392920 (UMLS CUI [1,2])
C0472699 (UMLS CUI [1,3])
ID.7
Item
pregnancy or breastfeeding
boolean
C0032961 (UMLS CUI [1,1])
C0006147 (UMLS CUI [1,2])
ID.8
Item
current active serious infection
boolean
C3714514 (UMLS CUI [1])
ID.9
Item
evidence of human immunodeficiency virus (hiv) or known hiv positive serology
boolean
C0019682 (UMLS CUI [1])
ID.10
Item
patients with acute leukemia in morphologic relapse/persistent disease defined as >5% blasts in a > or = 15% cellular bone marrow or any % blasts if blasts have unique morphologic markers (e.g., auer rods) or associated cytogenetic markers that allows morphologic relapse to be distinguished are not eligible.
boolean
C2367453 (UMLS CUI [1])
ID.11
Item
chronic myelogenous leukemia in refractory blast crisis.
boolean
C1370868 (UMLS CUI [1,1])
C0919644 (UMLS CUI [1,2])
ID.12
Item
active central nervous system malignancy.
boolean
C0085136 (UMLS CUI [1])